Cart
sales@molnova.com
TC-S 7005
CAS No. 1082739-92-1
TC-S 7005( —— )
Catalog No. M26838 CAS No. 1082739-92-1
TC-S 7005 is an inhibitor of Polo-like kinases (IC50s: 4 nM, 24 nM and 214 nM for Plk2, Plk3, and Plk1, respectively).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 134 | In Stock |
|
| 2MG | 72 | In Stock |
|
| 5MG | 121 | In Stock |
|
| 10MG | 188 | In Stock |
|
| 25MG | 354 | In Stock |
|
| 50MG | 520 | In Stock |
|
| 100MG | 698 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTC-S 7005
-
NoteResearch use only, not for human use.
-
Brief DescriptionTC-S 7005 is an inhibitor of Polo-like kinases (IC50s: 4 nM, 24 nM and 214 nM for Plk2, Plk3, and Plk1, respectively).
-
DescriptionTC-S 7005 is an inhibitor of Polo-like kinases (IC50s: 4 nM, 24 nM and 214 nM for Plk2, Plk3, and Plk1, respectively).(In Vitro):In human SR fibroblasts, TC-S 7005(1 μM) obviously causess myofibroblast differentiation and decrease fibroblast proliferation rates .
-
In VitroCell Proliferation Assay Cell Line:Primary human SR fibroblasts Concentration:1 μM Incubation Time:7 days Result:Markedly induced myofibroblast differentiation and reduced fibroblast proliferation rates.
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetPLK
-
RecptorCBP/p300| Cereblon
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1082739-92-1
-
Formula Weight359.385
-
Molecular FormulaC21H17N3O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (347.82 mM)
-
SMILESC[C@H](Nc1cc2c(noc2cn1)-c1ccc2OCOc2c1)c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Raghu Vannam, et al. Targeted degradation of the enhancer lysine acetyltransferases CBP and p300. Cell Chem Biol. 2020 Dec 31;S2451-9456(20)30513-4.
molnova catalog
related products
-
GW843682X
GW843682X is effective on inhibition of growth of tumor cells, with IC50s of 0.41, 0.57, 0.11, 0.38, and 0.70 μM for A549, BT474, HeLa, H460 and HCT116 cell lines.
-
Plogosertib
Plogosertib (CYC140) is an orally active, selective, potent, and ATP-competitive PLK1 inhibitor with an IC50 value of 3 nM.
-
Centrinone-B
Centrinone-B (LCR-323) is a potent and highly selective PLK4 inhibitor with a Ki of 0.59 nM.
